These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 6816068)
1. Defibrination with ancrod in glomerulonephritis: effects on clinical and histologic findings and on blood coagulation. Pollak VE; Glueck HI; Weiss MA; Lebron-Berges A; Miller MA Am J Nephrol; 1982; 2(4):195-207. PubMed ID: 6816068 [TBL] [Abstract][Full Text] [Related]
2. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects. Kim S; Wadhwa NK; Kant KS; Pollak VE; Glas-Greenwalt P; Weiss MA; Hong CG Q J Med; 1988 Nov; 69(259):879-905. PubMed ID: 3078212 [TBL] [Abstract][Full Text] [Related]
3. Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrod. Kant KS; Pollak VE; Dosekun A; Glas-Greenwalt P; Weiss MA; Glueck HI J Lab Clin Med; 1985 Jan; 105(1):77-88. PubMed ID: 3968467 [TBL] [Abstract][Full Text] [Related]
4. A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis. Tipping PG; Thomson NM; Holdsworth SR Br J Exp Pathol; 1986 Aug; 67(4):481-91. PubMed ID: 3741774 [TBL] [Abstract][Full Text] [Related]
6. Deficiency of a plasma factor stimulating vascular prostacyclin generation in patients with lupus nephritis and glomerular thrombi and its correction by ancrod: in-vivo and in-vitro observations. Kant KS; Dosekun AK; Chandran KG; Glas-Greenwalt P; Weiss MA; Pollak VE Thromb Res; 1982 Sep; 27(6):651-8. PubMed ID: 6758185 [TBL] [Abstract][Full Text] [Related]
7. Ancrod: normalization of fibrinolytic enzyme abnormalities in patients with systemic lupus erythematosus and lupus nephritis. Glas-Greenwalt P; Kant KS; Dosekun A; Frazier J; Allen C; Pollak VE J Lab Clin Med; 1985 Jan; 105(1):99-107. PubMed ID: 3871465 [TBL] [Abstract][Full Text] [Related]
8. Effects of ancrod and rtPA on fibrin accumulation, glomerular inflammation and renal function in nephrotoxic nephritis. Mathieson PW; Thiru S; Peters DK; Oliveira DB Int J Exp Pathol; 1991 Dec; 72(6):679-93. PubMed ID: 1768613 [TBL] [Abstract][Full Text] [Related]
10. Defibrination with ancrod in nephrotoxic nephritis in rabbits. Thomson NM; Moran J; Simpson IJ; Peters DK Kidney Int; 1976 Nov; 10(5):343-7. PubMed ID: 794557 [TBL] [Abstract][Full Text] [Related]
11. Platelet aggregation following defibrination with ancrod. Slade CL; Andes WA; Mason AD Thromb Haemost; 1976 Nov; 36(2):424-9. PubMed ID: 1036842 [TBL] [Abstract][Full Text] [Related]
12. Soluble fibrin complex production and proteolysis during ancrod therapy. McKillop C; Edgar W; Prentice CR; Forbes CD Scott Med J; 1975 May; 20(3):139-40. PubMed ID: 127379 [No Abstract] [Full Text] [Related]
14. The participation of macrophages, glomerular procoagulant activity, and factor VIII in glomerular fibrin deposition. Studies on anti-GBM antibody-induced glomerulonephritis in rabbits. Tipping PG; Holdsworth SR Am J Pathol; 1986 Jul; 124(1):10-7. PubMed ID: 3089018 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment by defibrination with ancrod in a patient with hyperacute renal allograft failure and a deficiency of plasma prostacyclin stimulating factor. Dosekun AK; First MR; Chandran PK; Kant KS; Glas-Greenwalt P; Weiss MA; Alexander JW; Pollak VE Clin Nephrol; 1982 Aug; 18(2):101-5. PubMed ID: 6754189 [TBL] [Abstract][Full Text] [Related]